Search

Your search keyword '"Jane R. Hanrahan"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Jane R. Hanrahan" Remove constraint Author: "Jane R. Hanrahan"
129 results on '"Jane R. Hanrahan"'

Search Results

1. Ceramide Regulates Anti-Tumor Mechanisms of Erianin in Androgen-Sensitive and Castration-Resistant Prostate Cancers

2. Traditional Uses, Phytochemistry and Pharmacological Activities of Annonacae

Catalog

Books, media, physical & digital resources

3. Pharmacological Effect of GABA Analogues on GABA-ϱ2 Receptors and Their Subtype Selectivity

4. Targeting GABAC Receptors Improves Post-Stroke Motor Recovery

5. The Phytochemical Constituents and Pharmacological Activities of Annona atemoya: A Systematic Review

6. Study of the Activity and Possible Mechanism of Action of a Reversible Inhibitor of Recombinant Human KAT-2: A Promising Lead in Neurodegenerative and Cognitive Disorders

7. The safety and tolerability of Annona muricata leaf product in people living with cancer: study protocol

8. Drug Targets for Biologics

9. Ceramide Regulates Anti-Tumor Mechanisms of Erianin in Androgen-Sensitive and Castration-Resistant Prostate Cancers

10. GABA allosteric modulators: An overview of recent developments in non-benzodiazepine modulators

11. Targeting GABA

12. Biologically active compounds from Lamiaceae family: Central nervous system effects

13. The Phytochemical Constituents and Pharmacological Activities of Annona atemoya: A Systematic Review

14. Roles of hydrophilic residues in GABA binding site of GABA-ρ1 receptor explain the addition/inhibition effects of competitive ligands

15. Molecular docking and antiamnesic effects of nepitrin isolated from Rosmarinus officinalis on scopolamine-induced memory impairment in mice

16. Crystal structure and mechanistic analysis of a novel human kynurenine aminotransferase-2 reversible inhibitor

17. GABA-ρ receptors: distinctive functions and molecular pharmacology

18. Spontaneous Adverse Event Reports Associated with Zolpidem in the United States 2003–2012

19. Effect of Antipsychotics and Non-Pharmacotherapy for the Management of Delirium in People Receiving Palliative Care

20. The safety and tolerability of Annona muricata leaf extract: a systematic review

21. Evaluation of a vaccination training program for pharmacy graduands in Australia

22. A pharmacological characterization of GABA, THIP and DS2 at binary α4β3 and β3δ receptors: GABA activates β3δ receptors via the β3(+)δ(−) interface

23. An Investigation of the Differential Effects of Ursane Triterpenoids fromCentella asiatica, and Their Semisynthetic Analogues, on GABAAReceptors

24. Exploring the Binding of Barbital to a Synthetic Macrocyclic Receptor. A Charge Density Study

25. Comparison of templates for homology model of ρ1 GABA C receptors: More insights to the orthosteric binding site’s structure and functionality

26. The flavonoid, 2'-methoxy-6-methylflavone, affords neuroprotection following focal cerebral ischaemia

27. Flavonoid Actions on Receptors for the Inhibitory Neurotransmitter GABA

28. Senior nurses' perspectives on the transfer of opioid substitution treatment clients from clinics to community pharmacy

29. A Hydrophobic Area of the GABA ρ1 Receptor Containing Phenylalanine 124 Influences Both Receptor Activation and Deactivation

30. GABAA Receptor Modulation by Compounds Isolated from Salvia triloba L

31. Modulation of Ionotropic GABA Receptors by 6-Methoxyflavanone and 6-Methoxyflavone

32. Factors influencing pharmacy services in opioid substitution treatment

33. Potency of GABA at human recombinant GABAA receptors expressed in Xenopus oocytes: a mini review

34. GABA-ρ receptors: distinctive functions and molecular pharmacology

35. Study of the Activity and Possible Mechanism of Action of a Reversible Inhibitor of Recombinant Human KAT-2: A Promising Lead in Neurodegenerative and Cognitive Disorders

36. Structure of the PLP-Form of the Human Kynurenine Aminotransferase II in a Novel Spacegroup at 1.83 Å Resolution

37. Structurally Diverse GABA Antagonists Interact Differently with Open and Closed Conformational States of the ρ1 Receptor

38. 2′-Methoxy-6-methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABAA receptors

39. Flavan-3-ol esters: new agents for exploring modulatory sites on GABAA receptors

40. Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q

41. Identification of Benzopyran-4-one Derivatives (Isoflavones) as Positive Modulators of GABAA Receptors

42. Flavonoid modulation of GABAAreceptors

43. Medicinal chemistry of ρ GABAC receptors

44. Neurochemicals for the Investigation of GABAC Receptors

45. Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology

46. γ-Hydroxybutyrate and the GABAergic footprint: a metabolomic approach to unpicking the actions of GHB

47. 7-Hydroxy-benzopyran-4-one Derivatives: A Novel Pharmacophore of Peroxisome Proliferator-Activated Receptor α and -γ (PPARα and γ) Dual Agonists

49. Ethnobotany, phytochemistry and pharmacology of the genus Caragana used in traditional Chinese medicine

50. The Flavonoid Glycosides, Myricitrin, Gossypin and Naringin Exert Anxiolytic Action in Mice